These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34218500)

  • 1. Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study.
    Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC;
    J Genet Couns; 2022 Feb; 31(1):96-108. PubMed ID: 34218500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer.
    Butow P; Davies G; Napier CE; Schlub T; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker B; Goldstein D; Thomas DM;
    JAMA Netw Open; 2020 May; 3(5):e204721. PubMed ID: 32407502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results.
    Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Best MC;
    Eur J Med Genet; 2022 Jun; 65(6):104516. PubMed ID: 35487418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):454. PubMed ID: 29685123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting.
    Best MC; Butow P; Savard J; Jacobs C; Bartley N; Davies G; Napier CE; Ballinger ML; Thomas DM; Biesecker B; Tucker KM; Juraskova I; Meiser B; Schlub T; Newson AJ
    Eur J Hum Genet; 2022 Aug; 30(8):930-937. PubMed ID: 35277654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer patient knowledge about and behavioral intentions after germline genome sequencing.
    Napier CE; Davies G; Butow PN; Schlub TE; Best MC; Bartley N; Juraskova I; Meiser B; Tucker KM; Biesecker BB; Thomas DM; Ballinger ML;
    Patient Educ Couns; 2022 Mar; 105(3):707-718. PubMed ID: 34247865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer patients' views and understanding of genome sequencing: a qualitative study.
    Bartley N; Best M; Jacobs C; Juraskova I; Newson AJ; Savard J; Meiser B; Ballinger ML; Thomas DM; Biesecker B; Butow P
    J Med Genet; 2020 Oct; 57(10):671-676. PubMed ID: 31980566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments.
    Goranitis I; Best S; Christodoulou J; Stark Z; Boughtwood T
    Genet Med; 2020 Aug; 22(8):1311-1319. PubMed ID: 32371919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who should access germline genome sequencing? A mixed methods study of patient views.
    Best MC; Butow P; Jacobs C; Savard J; Biesecker B; Ballinger ML; Bartley N; Davies G; Napier CE; Smit AK; Thomas DM; Newson AJ;
    Clin Genet; 2020 Feb; 97(2):329-337. PubMed ID: 31674008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing.
    Matro JM; Ruth KJ; Wong YN; McCully KC; Rybak CM; Meropol NJ; Hall MJ
    J Genet Couns; 2014 Dec; 23(6):1002-11. PubMed ID: 24794065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconception genome medicine: current state and future perspectives to improve infertility diagnosis and reproductive and health outcomes based on individual genomic data.
    Capalbo A; Poli M; Riera-Escamilla A; Shukla V; Kudo Høffding M; Krausz C; Hoffmann ER; Simon C
    Hum Reprod Update; 2021 Feb; 27(2):254-279. PubMed ID: 33197264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):389. PubMed ID: 29621994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay and time trade-off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains.
    Schiffner R; Brunnberg S; Hohenleutner U; Stolz W; Landthaler M
    Br J Dermatol; 2002 Mar; 146(3):440-7. PubMed ID: 11952544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Testing for Cancer Risk: Is the Community Willing to Pay for It?
    Aizuddin AN; Ramdzan AR; Syed Omar SA; Mahmud Z; Latiff ZA; Amat S; Teik KW; Siew CG; Rais H; Aljunid SM
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fear of cancer recurrence in patients undergoing germline genome sequencing.
    Bartley N; Davies G; Butow P; Napier CE; Schlub T; Ballinger ML; Thomas DM; Juraskova I; Meiser B; Best MC
    Support Care Cancer; 2021 Dec; 29(12):7289-7297. PubMed ID: 34036439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young adults' attitudes to sharing whole-genome sequencing information: a university-based survey.
    Barnard P; Sharples S; Thomson BJ; Garibaldi JM
    BMC Med Genomics; 2019 Apr; 12(1):55. PubMed ID: 30991996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Willingness to Pay for Faster Return to Work or Smaller Incisions.
    Alokozai A; Lindsay SE; Eppler SL; Fox PM; Ladd AL; Kamal RN
    Hand (N Y); 2021 Nov; 16(6):811-817. PubMed ID: 31791156
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling.
    Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Tucker K; Goldstein D; Biesecker BB; Best MC;
    Am J Med Genet A; 2022 Mar; 188(3):725-734. PubMed ID: 34755933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical providers' experiences with returning results from genomic sequencing: an interview study.
    Wynn J; Lewis K; Amendola LM; Bernhardt BA; Biswas S; Joshi M; McMullen C; Scollon S
    BMC Med Genomics; 2018 May; 11(1):45. PubMed ID: 29739461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Literacy of Registered Nurses and Midwives in Australia: A Cross-Sectional Survey.
    Wright H; Zhao L; Birks M; Mills J
    J Nurs Scholarsh; 2019 Jan; 51(1):40-49. PubMed ID: 30367730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.